Donald Trump has bought up virtually all stocks for the next three months of a drug shown to work against Covid-19. The US Department of Health and Human Services (HSS) said it had secured more than 500,000 treatment courses of remdesivir for American hospitals.
This represents 100% of the US pharmaceutical firm Gilead's projected production for July (94,200 treatment courses), 90% of production in August (174,900 treatment courses), and 90% of production in September (232,800 treatment courses), alongside an allocation for clinical trials.
Remdesivir is an anti-viral drug that was developed for use against Ebola. It has been approved for use in Covid-19 patients by the US and the UK, among other countries, after data suggested it can cut